A diabetes drug company is lobbying the Sask. government as Ottawa recommits to pharmacare
May 15, 2025
May 15, 2025
An international pharmaceutical company and a diabetes charity have registered to lobby the Saskatchewan government to expand coverage of medication and support for the chronic illness.
Last week, Eli Lilly — a major manufacturer — registered to lobby the province’s government to have its drugs publicly listed and reimbursed, and about “pan-Canadian pharmaceutical policy and pricing programs and initiatives; health system partnerships; pharmacare.”
The company creates drugs to address a range of issues, from cancer to arthritis and diabetes.
Under the national pharmacare program, certain diabetes and contraceptive drugs are covered by the federal government, including some of Eli Lilly’s insulin products.
During the federal election campaign, the Liberal Party promised to continue signing deals with provinces to implement the federal plan.
Before the election was called, Health Canada had negotiated deals with Prince Edward Island, Manitoba, Yukon and B.C. while Alberta and Quebec planned to opt out of the program.
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.